Incobotulinum Toxin A

DRUG7 trials

Sponsors

Beth Israel Deaconess Medical Center, Northwestern University, Pôle Saint Hélier, University of Minnesota, Instituto Mexicano del Seguro Social

Conditions

Amyotrophic Lateral SclerosisFunctionMultiple SclerosisPainParkinson DiseasePlantar Fasciitis of Both FeetProvoked VestibulodyniaSialorrhea

Early Phase 1

A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles

Active, not recruitingNCT02019004

Northwestern UniversityWrinkles

Start: 2013-11-01End: 2027-12-01Target: 20Updated: 2026-07-01

Phase 1

Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis

Active, not recruitingNCT06788158

Instituto Mexicano del Seguro SocialFunction, Pain, Plantar Fasciitis of Both Feet

Start: 2024-09-01End: 2025-04-01Target: 20Updated: 2025-01-23

Phase 2

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

WithdrawnNCT01565395

Beth Israel Deaconess Medical CenterAmyotrophic Lateral Sclerosis, Parkinson Disease

Start: 2012-03-31End: 2013-07-31Updated: 2017-02-07

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

CompletedNCT01653132

Beth Israel Deaconess Medical CenterSialorrhea

Start: 2012-03-31End: 2014-09-30Updated: 2017-03-14

The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

CompletedNCT05650645

University of MinnesotaTinnitus

Start: 2023-01-01End: 2025-12-29Updated: 2026-02-10

IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction

RecruitingNCT07486830

Center for Vulvovaginal DisordersProvoked Vestibulodynia

Start: 2026-02-27End: 2027-03-03Target: 54Updated: 2026-03-23

Unknown Phase

Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis

CompletedNCT04265092

Pôle Saint HélierMultiple Sclerosis

Start: 2014-01-31End: 2019-01-31Updated: 2020-02-11